Company / Inventory
Theravance Biopharma, Inc. Inventory History
FY2016-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$16.8M
FY2017
5-year range
-
FY2016-FY2017
Trend
+37.7%
vs FY2016
Sector context
#81 of 105
Health Care
What the data says
Theravance Biopharma, Inc.'s inventory of $17M is lower than 77% of companies in the Health Care sector (FY2017).
Based on SEC 10-K filings.
$17M in FY2017.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 23% in Health CareTop 77% of 105This company $16.8M Sector average $885.3M
▼
-98.1% below sector average
Key checks
Key Insights
- In FY2017, inventory increased 37.7% year-over-year.
- Ranks #81 out of 105 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | $16.8M | +37.7% |
| FY2016 | $12.2M | -14.7% |
As of FY2017 · SEC 10-K · Updated Jun 30, 2026